NKTX as of Nov 1 · 14:01 ET
NKTXNasdaqPharmaceutical Preparations
Nkarta, Inc. · Brief
Next report
8 days
Nov 9 · after closeest.Q3 FY26
Expected move
Inputs2 of 8≥ implied
- avg implied
- ±23.3%
- avg realized
- ±10.3%
Nov 7 '24±52.6%▼−2.45%×0.05
Mar 26 '25±32.9%▲+43.80%×1.33
May 14 '25±10.5%▼−8.02%×0.77
Aug 12 '25±8.7%▲+12.76%×1.46
Q3 FY25±10.6%▲+2.55%×0.24
Q1 FY26±23.7%▲+0.47%×0.02
May 12 '26±22.2%▼−6.71%×0.30
Q2 FY26±25.3%▼−5.28%×0.21
quarterimplied−55%0+55%realized×
Q2 FY26±25.3%▼−5.28%×0.21
May '26±22.2%▼−6.71%×0.30
Q1 FY26±23.7%▲+0.47%×0.02
Q3 FY25±10.6%▲+2.55%×0.24
Aug '25±8.7%▲+12.76%×1.46
May '25±10.5%▼−8.02%×0.77
2 older reports
Mar '25±32.9%▲+43.80%×1.33
Nov '24±52.6%▼−2.45%×0.05
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 9 report · est.Bull2
+5.73%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26
Bear2 of 4
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
NKTX report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.